Sanofi (SNYNF) EBT Margin (2009 - 2026)

Sanofi (SNYNF) posted EBT Margin of 123.03% for Q2 2026, up 4.83% sequentially from 117.37% in Q1 2026, and up 134.0% YoY from 52.58% in Q2 2025.

Sanofi (SNYNF) EBT Margin (2009 - 2026) Analysis & Trends

Sanofi has reported EBT Margin for 18 years, with the latest figure at 123.03% in Q2 2026.

Quarterly EBT Margin rose 134.0% year-over-year to 123.03% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 164.97% (up 5493.0% YoY) and the FY2025 annual result came in at 14.15%, up 307.0% from the prior year.
EBT Margin climbed to 123.03% in Q2 2026 per SNYNF's latest filing, from 117.37% in the prior quarter.
Over five years, EBT Margin peaked at 123.03% in Q2 2026 and troughed at 127.64% in Q4 2025.
A 5-year average of 101.14% and a median of 117.7% in 2025 frame the typical range for EBT Margin.
The sharpest annual moves came in 2022 and 2025: EBT Margin soared 12288 bps in 2022, then plunged 19842 bps in 2025.
Over 5 years, EBT Margin stood at 122.83% in 2022, then slipped by 2 bps to 120.91% in 2023, then sank by 41 bps to 70.78% in 2024, then sank by 280 bps to 127.64% in 2025, then surged by 196 bps to 123.03% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 123.03%, 117.37%, and 127.64% for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data